Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
There is a risk too many people are being diagnosed as obese when "a more accurate" and "nuanced" definition is needed, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback